{"article": [{"url": "https://www.marketwatch.com/story/moderna-secures-another-472-million-from-us-for-covid-19-vaccine-efforts-2020-07-26", "published": 1595789240.0, "headline": "Moderna secures another $472 million from U.S. for COVID-19 vaccine efforts", "body": "Biotech company Moderna Inc. MRNA, +0.09% on Sunday announced the U.S. government has committed up to an additional $472 million to its efforts to develop a coronavirus vaccine. In a statement, the drug maker said the funding would go to late-stage clinical development, including an expanded Phase 3 study of its vaccine candidate. In April, Moderna was awarded up to $483 million from the government's Biomedical Advanced Research and Development Authority. \"Encouraged by the Phase 1 data, we believe that our mRNA vaccine may aid in addressing the COVID-19 pandemic and preventing future outbreaks,\" Moderna CEO St\u00e9phane Bancel said in a statement. Moderna shares have soared more than 270% this year as it has emerged as a front-runner to developing a COVID-19 vaccine."}]}